物產中大(600704.SH):控股子公司發起設立山東海洋生物醫藥基金 重點投資于海洋生物醫藥創新產業項目
格隆匯 9 月 14日丨物產中大(600704.SH)公佈,近日,公司控股子公司宏誠投資、宏誠投資旗下管理的宏騰醫藥與山東省新動能基金管理有限公司、威海市政府投資引導基金有限公司、威海南海科創投資有限公司、威海藍科新動能產業發展基金合夥企業(有限合夥)共同簽署了《山東省新舊動能轉換海耀海洋生物醫藥產業投資合夥企業(有限合夥)合夥協議》,旨在發揮合作各方優勢,重點投資于海洋生物醫藥創新產業項目,提升公司醫藥健康板塊的市場競爭力和內在價值。
宏誠投資作為普通合夥人,宏騰醫藥與其他認購方作為有限合夥人,共同發起設立山東海洋生物醫藥基金,總規模1.5億元。其中,宏誠投資認繳出資150萬元,佔比1%;宏騰醫藥認繳出資3850萬元,佔比25.67%。其他認購方認繳出資1.1億元,佔比73.33%。
山東海洋生物醫藥基金以醫藥新產品、新技術、新產業為主要方向,擬投向海洋生物醫藥創新產業項目,投資若干與存量醫藥資產為互補、具有行業前景和良好成長性的項目,孵化和培育若干家與公司現有醫藥化工供應鏈集成服務業務有協同、具備研發技術及平台優勢、有成長性的醫藥健康相關企業,有助於提升公司醫藥健康板塊的市場競爭力和內在價值,符合物產中大“一體兩翼”發展戰略,是公司化工供應鏈的進一步延伸。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.